Health

Is Silence Therapeutics' Valuation Outlook Under Pressure?

March 06, 2025 12:26 AM PST| By Team Kalkine Media

Highlights,BMO Capital Markets revises its valuation outlook to a lower level,Mixed expert views yield a consensus valuation level,Institutional investors adjust their positions recently,Operating within the biotechnology sphere, Silence Therapeutics...

Is Praxis Precision Medicines Redefining CNS Treatment Innovations?

March 05, 2025 10:18 PM PST| By Team Kalkine Media

Highlights,A recognized investment firm has revised EPS estimates for upcoming quarters.,Multiple research organizations have adjusted their financial evaluations, offering diverse market perspectives.,Institutional entities have notably altered thei...

Why Is Teleflex's Stock Performance Drawing Attention?

March 05, 2025 09:17 PM PST| By Team Kalkine Media

Highlights,Teleflex operates in the medical technology sector, focusing on devices for critical care and surgical applications.,Institutional investors continue adjusting their holdings, with recent activity reflecting portfolio changes.,The company'...

How Is MiMedx Group (NASDAQ:MDXG) Advancing in the Healthcare Sector?

March 05, 2025 09:08 AM PST| By Team Kalkine Media

Highlights,MiMedx Group specializes in developing and distributing placental tissue allografts for healthcare applications.,Institutional investors continue to engage with the company, making adjustments to their holdings.,The company's proprietary p...

How Is Capricor Therapeutics (NASDAQ:CAPR) Progressing in Its Clinical Trials?

March 05, 2025 08:45 AM PST| By Team Kalkine Media

Highlights,Capricor Therapeutics is a biotechnology company specializing in the development of treatments for rare disorders.,The company’s lead candidate, CAP-1002, is undergoing clinical trials for Duchenne muscular dystrophy.,Institutional investo...

How Is Abbott Laboratories (NYSE:ABT) Advancing in the Healthcare Industry?

March 05, 2025 08:14 AM PST| By Team Kalkine Media

Highlights,Abbott Laboratories operates in the healthcare sector, providing medical devices, diagnostics, nutrition products, and pharmaceuticals.,Institutional firms have adjusted their holdings, reflecting activity within the company.,The company c...

How Is CEL-SCI (NYSE:CVM) Expanding Its Immunotherapy Research?

March 05, 2025 08:02 AM PST| By Team Kalkine Media

Highlights,CEL-SCI is focused on developing immune system therapies, with its lead treatment, Multikine, targeting head and neck cancers.,Institutional firms have adjusted their holdings, with increased engagement from key financial entities.,The sto...

Will Globus Medical’s Earnings Recover After One-Time Costs?

March 05, 2025 05:25 AM PST| By Team Kalkine Media

Will Globus Medical’s Earnings Recover After One-Time Costs?

Is Senseonics Struggling To Keep Up In Medical Technology?

March 05, 2025 01:30 AM PST| By Team Kalkine Media

Is Senseonics Struggling To Keep Up In Medical Technology?

Is Avacta Group Plc's Recent Stock Movement a Cause for Concern?

March 04, 2025 09:13 AM PST| By Team Kalkine Media

Headlines,Avacta Group Plc,(LON:AVCT),shares experienced a 13.2% decline, trading as low as GBX 33 ($0.42) on Tuesday.,The company's market capitalization stands at £125.37 million, with a price-to-earnings ratio of -4.25 and a beta of 1.12.,Avacta o...

Is Cencora’s (NYSE:COR) Financial Leverage a Strength or Weakness?

March 04, 2025 09:00 AM PST| By Team Kalkine Media

Highlights,Cencora’s net debt stands at approximately $4.92 billion, with strong interest coverage.,Liabilities exceed cash and near-term receivables by $40.9 billion, but earnings growth supports debt management.,The company's EBIT grew by 15%, rein...

Is IQVIA Holdings (NYSE:IQV) Experiencing a Shift in Market Sentiment?

March 04, 2025 08:35 AM PST| By Team Kalkine Media

Highlights,IQVIA Holdings has reported strong earnings per share growth, exceeding market performance over the past five years.,The company’s share price has shown slower movement compared to its earnings expansion.,Despite recent declines, long-term...

How Has Nuvation Bio (NYSE:NUVB) Positioned Itself in the Oncology Market?

March 04, 2025 08:14 AM PST| By Team Kalkine Media

Highlights,Strong institutional interest as significant investments and holdings increase.,Positive market sentiment with multiple financial firms maintaining an optimistic stance.,Focus on innovative oncology treatments with an expanding product pip...

What Factors Are Driving Abbott Laboratories' (NYSE:ABT) Recent Market Activity?

March 04, 2025 04:00 AM PST| By Team Kalkine Media

Highlights,Abbott Laboratories has experienced a significant increase in stock value over recent months.,The company's return on equity (ROE) remains higher than the industry average, reflecting strong financial efficiency.,Abbott Laboratories mainta...

Is Extendicare Gaining Strength In The Healthcare Sector?

March 04, 2025 12:45 AM PST| By Team Kalkine Media

Highlights:,Extendicare Inc. shares reached a new yearly high during the latest trading session.,The company,operates,long-term care homes and provides publicly funded home health care services.,Trading volume remained active as the stock experienced...